Vertex Pharmaceuticals Incorporated (VRTX), headquartered in Boston, Massachusetts and founded in 1989, develops, manufactures and commercializes transformative medicines for serious diseases, with a primary focus on cystic fibrosis, sickle…
HQ: Boston, MA, United States of Americawww.vrtx.com
USD538.60-0.74%vs prev. close
Performance
1W
-1.55%
1M
+8.04%
3M
+6.50%
1Y
+23.95%
YTD
+18.80%
Valuation
P/E
34.7
EPS TTM
15.54
Dividend yield
—
Size and risk
Market cap
$136.6B
Beta
0.28
Price history
VRTX price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Vertex Pharmaceuticals
VRTX
Biotechnology
Mkt cap (USD bn)
136.6
P/E
34.7
Div yld
—
1W
-1.6%
1M
+8.0%
3M
+6.5%
6M
+23.3%
1Y
+23.9%
YTD
+18.8%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Vertex Pharmaceuticals
VRTX
Biotechnology
136.6
34.7
—
-1.6%
+8.0%
+6.5%
+23.3%
+23.9%
+18.8%
Subscribe to Equity Analytics to compare VRTX with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.